I am wondering what the IP separation is like with DROWZLE, I have read the sleep apnoea patent for ResApp from UQ researcher. Seems a little too specific to shield out this product. I guess it is a head to head competition, 2 products based on similar no overlapping technologies?
- Forums
- ASX - By Stock
- RAP
- Ann: At-Home Obstructive Sleep Apnoea Study Update
Ann: At-Home Obstructive Sleep Apnoea Study Update, page-199
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online